Bydureon combined with Byetta

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Abdominal Pain Upper Other Serious 12/15/2011 63 Female 2/8/2012 Other Health Professional Germany
Primary
Secondary
Concomitant
Blood Glucose Increased Hospitalization 1/24/2012 73 Male 293 lb 4/2/2012 Consumer Germany
Primary
Concomitant
Deep Vein Thrombosis Other Serious 61 Male 4/12/2012 Consumer United States
Primary
Concomitant
Injection Site Nodule Hospitalization 2/15/2012 79 Male 175 lb 4/25/2012 Consumer United States
Primary
Concomitant
Arrhythmia Other Serious Male 247 lb 4/26/2012 Consumer United States
Primary
Secondary
Concomitant
Neck Pain Other Serious 4/30/2012 34 Female 5/3/2012 Physician United States
Primary
Secondary
Concomitant
Speech Disorder Other Serious 4/18/2012 53 Female 280 lb 5/3/2012 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Decreased Other Serious Female 5/10/2012 Consumer United States
Primary
Concomitant
Panic Disorder Other Serious 4/1/2012 67 Female 5/18/2012 Consumer United States
Primary
Secondary
Concomitant
Injection Site Nodule Other Serious Female 5/23/2012 Physician United States
Primary
Concomitant
Glycosylated Haemoglobin Increased Other Serious 5/2/2012 60 Female 5/22/2012 Consumer United States
Primary
Secondary
Concomitant
Fatigue Other Serious 5/15/2012 71 Male 185 lb 6/6/2012 Consumer United States
Primary
Secondary
Concomitant
Menopause Other Serious Female 6/6/2012 Consumer United States
Primary
Concomitant
Weight Decreased Other Serious 5/2/2012 60 Female 306 lb 6/7/2012 Consumer United States
Primary
Secondary
Concomitant
Injection Site Nodule Other Serious Female 6/14/2012 Consumer United States
Primary
Secondary
Fatigue Other Serious 5/15/2012 71 Male 185 lb 6/15/2012 Consumer United States
Primary
Secondary
Concomitant
Underdose Life Threatening 1/1/2006 59 Male 230 lb 6/15/2012 Consumer United States
Primary
Secondary
Concomitant
Abdominal Pain Upper Hospitalization Male 6/21/2012 Consumer United States
Primary
Secondary
Swelling Face Other Serious 4/28/2012 58 Female 232 lb 6/25/2012 Consumer United States
Primary
Secondary
Concomitant
Influenza Other Serious 5/15/2012 71 Male 185 lb 6/27/2012 Consumer United States
Primary
Secondary
Concomitant
Respiratory Tract Infection Viral Other Serious 6/1/2012 58 Female 215 lb 7/5/2012 Consumer United States
Primary
Secondary
Concomitant
Muscle Spasms Other Serious Female 230 lb 7/3/2012 Consumer United States
Primary
Concomitant
Blood Creatinine Increased Other Serious 5/15/2012 71 Male 188 lb 7/5/2012 Consumer United States
Primary
Secondary
Concomitant
Product Substitution Issue Other Serious Female 7/13/2012 Consumer United States
Primary
Secondary
Concomitant
Ileus Paralytic Other Serious 5/1/2012 64 Male 284 lb 7/16/2012 Physician United States
Primary
Secondary
Concomitant
Prostate Cancer Hospitalization 11/1/2011 56 Male 7/18/2012 Physician Germany
Primary
Secondary
Concomitant
Tachycardia Other Serious Female 7/23/2012 Physician United States
Primary
Secondary
Injection Site Pruritus Other Serious Female 7/27/2012 Consumer United States
Primary
Concomitant
Malaise Other Serious Male 8/3/2012 Consumer United Kingdom
Primary
Secondary
Concomitant
Hypersensitivity Other Serious 4/28/2012 58 Female 232 lb 8/3/2012 Consumer United States
Primary
Secondary
Concomitant
Coronary Angioplasty Other Serious 11/19/2009 Male 8/17/2012 Consumer Germany
Primary
Secondary
Concomitant
Atrioventricular Block First Degree Other Serious 8/1/2012 64 Male 200 lb 8/20/2012 Consumer United States
Primary
Secondary
Concomitant
Nephrolithiasis Other Serious 3/19/2012 56 Male 8/20/2012 Consumer Germany
Primary
Secondary
Concomitant
Adenocarcinoma Pancreas Other Serious 3/2011 Male 3/11/2013 Consumer Us
Primary
Secondary
Adenocarcinoma Pancreas Other Serious 12/16/2010 57 Female 1/16/2013 Other Health Professional Us
Primary
Secondary
Concomitant
Coronary Angioplasty Hospitalization 5/10/2010 Male 9/7/2012 Physician De
Primary
Secondary
Concomitant
Malaise Other Serious 3/2012 Female 250 lb 12/14/2012 Physician Us
Primary
Concomitant
Weight Decreased Other Serious 8/2011 Female 145 lb 8/30/2012 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious Female 180 lb 9/11/2012 Consumer Us
Primary
Secondary
Concomitant
Weight Increased Other Serious 7/2012 Female 115 lb 12/11/2012 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 8/2012 Male 245 lb 9/14/2012 Consumer Us
Primary
Secondary
Concomitant
Erythema Multiforme Other Serious 7/14/2012 61 Female 235 lb 1/11/2013 Physician Gb
Primary
Concomitant
Weight Increased Other Serious 9/11/2012 Female 10/22/2012 Consumer Us
Primary
Secondary
Concomitant
Swelling Face Other Serious Female 10/11/2012 Consumer Us
Primary
Secondary
Weight Decreased Other Serious 5/2009 Female 11/9/2012 Consumer Us
Primary
Secondary
Concomitant
Spinal Fusion Surgery Other Serious Male 10/25/2012 Consumer Us
Primary
Secondary
Concomitant
Urticaria Other Serious 10/2012 Male 10/26/2012 Consumer Us
Primary
Secondary
Concomitant
Sciatica Other Serious Female 179 lb 12/21/2012 Physician Us
Primary
Secondary
Concomitant
Wrong Technique In Drug Usage Process Other Serious 6/21/2012 60 Female 12/5/2012 Physician Us
Primary
Concomitant
Presyncope Other Serious 4/5/2012 57 Female 224 lb 12/14/2012 Consumer Us
Primary
Secondary
Concomitant
Benign Neoplasm Of Thyroid Gland Other Serious 9/7/2012 72 Female 159 lb 12/17/2012 Consumer Gb
Primary
Secondary
Concomitant
Off Label Use Hospitalization Female 12/18/2012 Consumer Gb
Primary
Secondary
Vomiting Other Serious 11/6/2012 64 Male 195 lb 12/20/2012 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 12/2012 Female 178 lb 3/22/2013 Physician Us
Primary
Secondary
Concomitant
Pancreatic Carcinoma Death 3/2009 NotSpecified 1/4/2013 Consumer Us
Primary
Secondary
Concomitant
Pancreatic Carcinoma Death 3/2009 Male 1/11/2013 Consumer Us
Primary
Secondary
Weight Decreased 2011 Female 272 lb 2/19/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2009 68 Male 175 lb 1/12/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2012 Female 153 lb 2/1/2013 Consumer Us
Primary
Secondary
Concomitant
Urticaria Other Serious 1/18/2013 Female 2/1/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious Female 185 lb 3/8/2013 Physician Us
Primary
Secondary
Concomitant
Pancreatic Carcinoma Death 3/2009 Male 2/1/2013 Consumer Us
Primary
Secondary
Nausea Other Serious Female 158 lb 3/8/2013 Physician Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2012 Female 230 lb 2/8/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/22/2013 76 Female 165 lb 2/8/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious Female 217 lb 2/27/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious Male 230 lb 2/28/2013 Consumer Us
Primary
Secondary
Concomitant
Underdose Other Serious 2/23/2013 67 Female 132 lb 3/5/2013 Consumer Us
Primary
Concomitant
Wound Infection Staphylococcal Other Serious 6/2012 Female 214 lb 3/7/2013 Consumer Us
Primary
Secondary
Concomitant
Endometrial Cancer Other Serious 54 Female 3/7/2013 Consumer Gb
Primary
Secondary
Concomitant
Nausea Other Serious 1/2013 52 Male 271 lb 4/1/2013 Consumer Us
Primary
Secondary
Concomitant
Glycosylated Haemoglobin Increased Other Serious 10/2012 Female 189 lb 3/14/2013 Consumer Us
Primary
Secondary
Injection Site Pain Other Serious 12/21/2012 55 Male 208 lb 3/15/2013 Consumer Us
Primary
Secondary
Concomitant
Rash Generalised Other Serious 3/8/2012 44 Female 193 lb 11/15/2012 Consumer Us
Primary
Secondary
Concomitant
Injection Site Haemorrhage Other Serious 2/2013 Male 319 lb 3/21/2013 Consumer Us
Primary
Secondary
Concomitant
Hallucination, Visual Other Serious Female 3/22/2013 Consumer Us
Primary
Secondary
Concomitant
Uterine Cancer Other Serious Female 192 lb 3/28/2013 Other Health Professional Us
Primary
Secondary
Concomitant
Urticaria Other Serious Female 4/2/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 62 Female 185 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Pancreatitis Other Serious Male 11/15/2012 Physician Us
Primary
Secondary
Lymphoma Other Serious 2010 Female 148 lb 4/3/2013 Consumer Us
Primary
Secondary
Concomitant
Wound Infection Staphylococcal Hospitalization 6/2012 63 Female 214 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Vomiting Hospitalization 60 Female 199 lb 11/15/2012 Us
Primary
Secondary
Concomitant
Pancreatitis Other Serious Female 11/17/2012 Other Health Professional Us
Primary
Secondary
Pancreatitis Other Serious 70 Male 11/15/2012 Registered Nurse Us
Primary
Secondary
Concomitant
Pancreatitis Hospitalization 65 Male 11/15/2012 Physician Us
Primary
Secondary
Concomitant
Oedema Peripheral Other Serious 4/19/2013 84 Male 223 lb 5/16/2013 Physician Us
Primary
Secondary
Concomitant
Pancreatic Cyst Other Serious Female 5/10/2013 Consumer Us
Primary
Secondary
Underdose Other Serious 2/23/2013 67 Female 132 lb 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 70 Female 158 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 3/14/2013 52 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Haemorrhage 2012 Male 5/25/2013 Consumer Us
Primary
Secondary
Injection Site Haemorrhage Other Serious 2/2013 54 Male 319 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 47 Female 130 lb 5/25/2013 Consumer Us
Primary
Secondary
Weight Decreased 60 Male 225 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 3/1/2013 49 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use 3/10/2013 55 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Nodule 70 Female 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Urticaria Other Serious Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 63 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Off Label Use 3/5/2013 67 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Nodule 60 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Salivary Duct Obstruction 2/22/2013 49 Female 187 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Incorrect Dose Administered 2/25/2013 Female 5/25/2013 Consumer Us
Primary
Secondary
Off Label Use 2013 55 Female 174 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Abdominal Distension 60 Male 190 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Nodule 2/2013 73 Male 190 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Increased 53 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Palpitations 12/5/2012 60 Female 258 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Blood Glucose Increased 2/16/2013 60 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Headache Male 5/25/2013 Consumer Us
Primary
Secondary
Blood Glucose Increased Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 2010 71 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Sleep Disorder 2005 74 Male 170 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pain 57 Female 143 lb 5/25/2013 Consumer Us
Primary
Concomitant
Tremor 3/13/2013 60 Female 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Pain Female 5/25/2013 Consumer Us
Primary
Concomitant
Underdose 3/14/2013 58 Male 5/25/2013 Consumer Us
Primary
Concomitant
Off Label Use 72 Female 5/25/2013 Consumer Us
Primary
Concomitant
Weight Decreased Other Serious 2/16/2013 62 Female 200 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 2/2012 80 Male 171 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Nodule 1/2013 Male 5/25/2013 Consumer Us
Primary
Concomitant
Blood Glucose Increased 2008 48 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Haemorrhage 3/3/2013 84 Female 190 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Pruritus 56 Male 5/25/2013 Consumer Us
Primary
Secondary
Weight Increased 71 Female 230 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Mass 2/2013 68 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea Other Serious 1/2013 52 Male 271 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 3/16/2013 68 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 68 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Underdose 3/14/2013 58 Male 5/25/2013 Consumer Us
Primary
Concomitant
Myalgia Female 5/25/2013 Consumer Us
Primary
Secondary
Myalgia Female 5/25/2013 Consumer Us
Primary
Secondary
Uterine Cancer Other Serious 3/2013 56 Female 192 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 9/2012 53 Male 230 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Injection Site Haemorrhage 3/3/2013 70 Female 5/25/2013 Consumer Us
Primary
Secondary
Weight Decreased 64 Male 191 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Underdose 6/2012 Male 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Nausea 6/2012 38 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased 8/28/2012 60 Female 291 lb 5/25/2013 Physician Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2011 51 Female 180 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Underdose 3/24/2013 77 Female 5/25/2013 Consumer Us
Primary
Concomitant
Injection Site Nodule 62 Female 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Female 201 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Female 199 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Weight Decreased Hospitalization 3/2008 51 Male 240 lb 5/25/2013 Consumer Us
Primary
Secondary
Concomitant
Atrial Fibrillation Other Serious 5/23/2013 64 Female 200 lb 6/25/2013 Physician Us
Primary
Secondary
Concomitant
Weight Decreased Other Serious 2011 Female 180 lb 1/4/2013 Consumer Us
Primary
Secondary
Weight Decreased Hospitalization 2010 Female 248 lb 1/4/2013 Consumer Us
Primary
Secondary
Concomitant

Drug Data